Celltrion’s Vegzelma Becomes Fourth US-Approved Bevacizumab

Estimated US Market Launch Date Is H1 2023

Label that reads "FDA APPROVED" on top a portion of the American Flag
• Source: Shutterstock

More from Biosimilars

More from Products